drugset / Trial / NCT02685852
Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of the study is to evaluate the effectiveness of exenatide in adults experiencing episodes of hyperinsulinemic hypoglycemia following Roux-en-Y bariatric surgery.
Timeline
- Start
- 2016-02
- Primary completion
- 2019-07-22
- Completion
- 2019-07-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acarbose | Unknown | 25 mg | — |
| Comparator | Exenatide | Peptide | 5 ug | — |